Pfizer rebound keeps dividend stable, HSBC lowers upside by $23 billion
Pfizer Inc. traded up 1.7% at $24.13 as of 11:48 a.m. EDT Tuesday, recovering some ground after Monday’s 2.47% slide to $23.72. The stock’s loss on Monday stood out with the S&P 500 up 0.72% and the Dow up 0.29%, making it a clear underperformer, not just a victim of the broader market.
